Frailty profile precluding standard 6-week TMZ chemoradiation in glioblastoma: KPS <70, E...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-GBM-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-27 | pending_clinical_signoff |
| Diseases | DIS-GBM |
| Sources | SRC-EANO-GBM-2024 SRC-NCCN-CNS-2025 |
Red Flag Origin
| Definition | Frailty profile precluding standard 6-week TMZ chemoradiation in glioblastoma: KPS <70, ECOG ≥3, OR (age ≥70 with declining functional status), OR composite frailty (age ≥75 + Charlson ≥3). Routes to hypofractionated RT (15 fractions) ± concurrent TMZ per Perry/CCTG-CE.6 elderly trial, or RT alone, or best supportive care. |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
Trigger Logic
{
"any_of": [
{
"comparator": "<",
"finding": "kps",
"threshold": 70
},
{
"comparator": ">=",
"finding": "ecog",
"threshold": 3
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 70
},
{
"finding": "functional_decline",
"value": true
}
]
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 75
},
{
"comparator": ">=",
"finding": "charlson_score",
"threshold": 3
}
]
}
],
"type": "composite_score"
}
Notes
Perry CCTG-CE.6 (NEJM 2017) established hypofractionated RT 40 Gy / 15 fx + concurrent TMZ + adjuvant TMZ as standard for elderly (≥65) GBM — OS 9.3 mo vs 7.6 mo for RT alone; benefit largest in MGMT-methylated. KPS <60 / ECOG 4: best supportive care + steroids + anti-epileptics (no survival benefit demonstrated for active cancer treatment in this group). KPS 60-70: hypofractionated RT alone (40 Gy / 15 fx) reasonable. Avoid bevacizumab in elderly unfit (no OS benefit, adds AE).
Used By
No reverse references found in the YAML corpus.